Clinical sign | Number of animals (% of all reported non-cutaneous AFR) | Strength of evidence |
---|---|---|
Diarrhoea [9,10,11,12,13,14,15,16,17,18,19, 22,23,24,25,26,27, 32,33,34,35,36,37,38,39,40,41,42,43,44, 47, 48] | 391–490a (70–88%) | Strong in 36–39a [9,10,11,12,13,14,15,16,17,18,19, 48] |
Vomiting [9, 11, 13,14,15, 17, 18, 22,23,24,25,26,27, 33, 34, 40, 42, 43] | 28–115a (5–21%) | Strong in 6–47a [9, 11, 13,14,15, 17, 18] |
33 (6%) | Strong in 16 [45] | |
Tenesmus [45] | 11 (2%) | Strong in 11 |
Paroxysmal gluten-sensitive dyskinesia of Border terriers [49] | 5 (1%) | Strong in 2 Weak in 3 |
Symmetrical lupoid onychodystrophy [50] | 4 (1%) | Strong in 2 Weak in 2 |
Anaphylaxis [40] | 1 (0.2%) | Weak |
Conjunctivitis [12] | 1 (0.2%) | Strong |
Asthma [27] | 1 (0.2%) | Moderate |
Sneezing [14] | 1 (0.2%) | Strong |